Skip to content

Iris Acquisition IRAB Payments Of Stock Issuance Costs

Payments Of Stock Issuance Costs at other companies

IRA
Iris Acquisition IRAB
$10.61M
EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
$297K+119%
TRV
Trevi Therapeutics, Inc.TRVI
$0
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
$65.65K+260%
Rumble, Inc. logo
Rumble, Inc.RUM
$29.43M+32,132%
Diversified Energy
 logo
Diversified Energy DEC
$6M

Other financials

Income statement

See full
Operating income-$144.1K
Net income$773.9K

Balance sheet

See full
Cash & equivalents$854.8K
Total debt$84.6K
Total equity-$6.4M
Total assets$170.4M

Cash flow

See full
Operating cash flow-$9.8K

Valuation

See full
Market cap$227.44M+0.2%
Enterprise value$226.67M

Returns & leverage

See full
Debt / equity-0×
Current ratio2.9×

Where this comes from

Reported directly by Iris Acquisition in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfStockIssuanceCosts.

The official record: Iris Acquisition ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Iris Acquisition 's payments of stock issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Iris Acquisition 's payments of stock issuance costs?
Iris Acquisition (IRAB) reported payments of stock issuance costs of $10.61M in Q1 2026.
What does payments of stock issuance costs mean?
Captures the direct costs incurred in connection with the issuance of equity securities, such as legal, accounting, and registration fees. These costs are typically deducted from the proceeds of the stock offering. Monitoring these expenses helps assess the efficiency of the company's capital raising activities.